The Gotfried percutaneous compression plate compared with the conventional classic hip screw for the fixation of intertrochanteric fractures of the hip
Sir, I was most interested to read the paper by Kosygan et al1 in the January 2002 issue entitled a 'The Gotfried percutaneous compres- sion plate compared with the classic hip screw for the fixation of intertrochanteric fractures of the hip'. The authors conclude that the minimally invasive percutaneous compression plating (PCCP) procedure has theoretical rather than practical advantages and that in the present study "no practical benefit was associated with its use". On the basis of postoperative complications alone, it is difficult to see how they arrive at this conclusion. They report a total of six complications (11.5%) in the PCCP group and 21 (37.5%) in the classic hip screw (CHS) group (Table III). The magnitude of this difference was ignored by the authors and not subjected to statistical analysis. Using the chi- squared test, an independent statistician has found this difference to be clearly significant (p = 0.0014). Furthermore, the complica- tions described include chest infections (one in the PCCP group, four in the CHS group) and cardiac complications (one in the PCCP group, six in the CHS group). Despite these findings, the authors state that "the complications after operation were similar in both groups". This merits some explanation. Since in addition blood loss and transfusion requirements were less in the PCCP group, the practical advantages and benefits speak for themselves. This study demonstrates that reducing surgical trauma in this group of patients (mean age 82 years) significantly reduced post- operative morbidity. There are a number of important principles associated with the use of the PCCP foremost of which is prudent reduction of the fracture. Regrettably, this principle has been misunderstood by the authors, leading them to conclude that because the PCCP is a fixed-angle device it cannot be universally applicable. In current practice, the appropriate angle of a CHS/DHS plate is determined by the neck-shaft angle achieved on reduction of the fracture. Thus CHS/DHS plates with various degrees of valgus and varus are available with these devices. In marked contrast, the PCCP philosophy is that of adapting the fracture to the angu- lar configuration of the plate, i.e. of reducing the fracture to a neck-shaft angle of 135°. No varus angulation (neck-shaft angle less than 135°) is accepted. The rationale of this technique is to subject the fracture and the sliding fixation device to a compres- sive load rather than a bending load. In practice, this can be achieved very simply. When the fracture is initially in varus, this is done by simply applying suitable traction on the fracture table, or when there is excessive valgus, by releasing traction. The ultimate result will be a neck-shaft angle of 135° without any material change in the reduction. This technique is most important in unstable fractures with multiple fragments. During reduction, a template on the image-intensifier screen is used to verify that the desired angle of 135° has been achieved. Another cardinal principle of the PCCP technique, not addressed by the authors, is the reduction of sagging of the poste- rior fracture and the maintenance of this reduction for the entire duration of the operation. Dedicated instrumentation has been developed to accomplish this task efficiently and without undue effort on the part of the assistant, as described previously.2 A further feature of the PCCP procedure is fixation using double telescoping neck screws as opposed to single-axis fixa- tion with the CHS. This provides rotational stability to the femo- ral neck-head fragment, with the aim of preventing cut-out.3 In support of this, the authors report no cut-outs in the PCCP group but two in the CHS group, which were revised to intramedullary fixation. Cut-out is a frequently reported complication with CHS/DHS devices, but none was observed in association with the PCCP. It is surprising that the authors failed to comment on this finding. Independent, randomised prospective studies are needed to confirm the results obtained by the inventor2 and these should include assessment of all the appropriate parameters. The present study1 has not considered any functional outcomes, which must be an integral part of any such investigation. In addition, in regard to the PCCP, the important concept of preservation of the lateral tro- chanteric wall2 has received no mention. The statement in the abstract which claims that at six months there was no difference in rates of healing of the fracture or in failure of the implant is not referred to at all in the Results section, which clearly implies that these parameters were not formally evaluated in the study. Finally, no reference is made to a recently published paper, which looks at the results of 97 patients treated with the PCCP, and includes func- tional results.2 According to the authors' findings the learning curve involved only two cases, in the 52 patients 30 units of blood were saved, there was a significant reduction in postoperative complications and there were no 'cut-outs'. What therefore has led them to con- clude that "we cannot therefore recommend its (PCCP) wide- spread introduction at this time"? On the basis of their findings should not their conclusion be exactly the opposite?